| |
The point-of-care testing (POCT) market continues to evolve due to movements in the competitive landscape and expanding market opportunities. Companies have responded to new opportunities and growing end-user needs aggressively through expansion of product lines and test capabilities.
Frost & Sullivan (drugdiscovery.frost.com) finds that the U.S Point-of-Care Testing Market earned revenues of $2.13 billion in 2009 and estimates this to reach $3.93 billion in 2016.
"New opportunities continue to emerge for point-of-care testing," explains Frost & Sullivan Research Analyst Isaac Middendorf. "Testing is increasingly utilized in new environments, such as patient homes, as well as in novel disease areas."
The POCT market continues to be driven largely by high-growth segments such as infectious disease and coagulation PT monitoring. The infectious disease market has been driven by rising infections and detection of new diseases and mutations. Coagulation PT monitoring has grown dramatically due to expanded testing in patient homes and the growth of patient services.
"Growing testing channels have driven test utilization, while new products continue to expand the areas in which point-of-care testing can add value," continues Middendorf. "As more testing methods move into areas such as the patient’s home, it is expected to drive not only test use and compliance, but also additional revenue areas such as patient services and monitoring. Additionally, new areas continue to emerge that may benefit from point-of-care methods, including new diseases and ways to monitor therapy efficacy."
If you are interested in more information on this study, please send an email to Johanna Haynes, Corporate Communications, at johanna.haynes[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
U.S. Point-of-care Testing (POCT) Markets-2009 / N6E5-55
|
johanna.haynes[]frost.com 
